Osteoporosis Therapy With Denosumab in Organ Transplant Recipients
ObjectiveOsteoporosis and fragility fractures represent serious complications for the solid organ transplant population. The recommended osteoporosis therapy for organ recipients involves supplementation with calcium and vitamin D and bisphosphonate administration. However, these options can prove l...
Main Authors: | Jana Brunova, Simona Kratochvilova, Jitka Stepankova |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-04-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fendo.2018.00162/full |
Similar Items
-
Effect of Denosumab on Peripheral Compartmental Bone Density, Microarchitecture and Estimated Bone Strength in De Novo Kidney Transplant Recipients
by: Marco Bonani, et al.
Published: (2016-09-01) -
Denosumab treatment for osteopenia or osteoporosis in heart transplant recipients: Effects and safety
by: Juan C. Uzquiano, et al.
Published: (2022-09-01) -
Optimization of osteoporosis and osteopenia management among renal transplant recipients
by: Mohammed K. Afifi, et al.
Published: (2021-11-01) -
Inverse association of serum osteocalcin and bone mineral density in renal transplant recipients
by: Wei-Chen Lin, et al.
Published: (2023-01-01) -
Pharmacological Therapy of Osteoporosis: A Systematic Current Review of Literature
by: Vito Pavone, et al.
Published: (2017-11-01)